@article{55e0b85b9731488d90d38d035619095f,
title = "Diagnostic performance of 1,5-anhydroglucitol compared to 2-h glucose in the Atherosclerosis risk in communities study",
author = "Bethany Warren and Lee, {Alexandra K.} and Ballantyne, {Christie M.} and Hoogeveen, {Ron C.} and Pankow, {James S.} and Morgan Grams and Anna K{\"o}ttgen and Elizabeth Selvin",
note = "Funding Information: tyne, Abbott, Roche Diagnostics; R.C. Hoo-geveen, Denka Seiken. Stock Ownership: None declared. Honoraria: None declared. Research Funding: The Atherosclerosis Risk in Communities study is carried out as a collaborative study supported by the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Department of Health and Human Services, under the following contracts: HHSN268201700001I, HHSN268201700003I, HHSN268201700 005I, HHSN268201700004I, HHSN2682 01700002I. Reagents for the 1,5-anhydroglucitol assays were donated by GlycoMark, Inc. B. Warren, NIH/NHLBI grant T32 HL007024; A.K. Lee, NIH/NHLBI grant T32 HL007024; E. Selvin, NIH/NIDDK grants K24DK10 6414 and R01DK089174. Expert Testimony: None declared. Patents: C.M. Ballantyne, 61721475.",
year = "2018",
month = oct,
doi = "10.1373/clinchem.2018.291773",
language = "English (US)",
volume = "64",
pages = "1536--1537",
journal = "Clinical chemistry",
issn = "0009-9147",
publisher = "American Association for Clinical Chemistry Inc.",
number = "10",
}